Concept · medicine
Metabolic syndrome
4 studies
Metabolic syndrome is a cluster of metabolic disturbances (central obesity, dysglycemia, dyslipidemia, hypertension) that raise cardiometabolic risk. Study layers here separate microbiome–metabolite associations, epigenetic age acceleration with incident MetS, acute phenol-driven transcript shifts, and common-SNP heritability of MetS traits.
Students treat “MetS” as one pathway and one diet tip. Microbiome correlations, methylation clocks, postprandial olive-oil transcripts, and SNP heritability answer different questions. Mixing them invents false agreement about cause and treatment.
Studies
4
Findings
4
4 supporting · 0 challenging · 5 qualifying citations
Open tensions
2
Currently
What we know
- Gut microbiota composition associates with metabolites and MetS-related traits in men.
- Higher MetS severity tracks faster epigenetic aging; year-20 IEAA predicts later incident MetS.
- High-phenol virgin olive oil acutely changes inflammatory gene programs in MetS PBMCs.
- Common GWAS SNPs capture a large share of MetS-trait heritability.
Largest unresolved question
Microbiome correlates, methylation-age risk, acute dietary transcript shifts, and SNP heritability all sit under MetS without sharing one assay or one intervention claim.
Common misconceptions
Any MetS molecular finding is a ready lifestyle or drug prescription.
Microbiome associations, epigenetic clocks, postprandial transcripts, and SNP heritability need different evidence standards before becoming treatments.
High-phenol olive oil’s gene changes mean MetS is cured after one breakfast.
The study measured acute PBMC expression differences vs low-phenol oil — not long-term syndrome remission.
If common SNPs explain heritability, MetS is purely genetic and lifestyle is irrelevant.
Heritability partitions variance; it does not erase environmental or behavioural causes or treatments.
Related
Claim ledger
What the evidence shows
Drawn from 4 studies in this library. Mix labels say which citation roles are present; they are not a strength score. Supports means evidence for a finding; Challenges means evidence against a stated position; Qualifies marks scope.
Gut microbiota composition associates with metabolites and MetS-related traits in men.
In middle-aged men, gut microbiota composition associated with plasma metabolites and metabolic-syndrome–related traits — a microbiome correlate of MetS biology, not a proof that changing stool taxa remits the syndrome.
- Common SNPs explain much of MetS-trait heritability— different level — common-SNP heritability of MetS traits, not stool microbiota
- Faster epigenetic aging tracks metabolic syndrome risk in CARDIA— different aging/epigenetic readout — not microbiome metabolites
Study Role Design N Population Outcome Gut microbes, blood metabolites, and metabolic traits Supports Cross-sectionalMETSIM subset microbiome–metabolite–metabolic trait association analysis N=531 · 531 middle-aged Finnish men from the METSIM cohort (parent cohort 10,197) Middle-aged Finnish men in METSIM Associations of gut microbiota with plasma metabolites and metabolic traits Common SNPs explain much of MetS-trait heritability Qualifiesdifferent level — common-SNP heritability of MetS traits, not stool microbiota Computational / modellingGREML-style common-SNP heritability (hg²) vs pedigree h² in ARIC (FHS checks) N=8451 · ARIC GWAS analysis population for MetS trait hg² estimates ARIC (and FHS check) participants with genome-wide SNP data and MetS traits Common-SNP heritability and genetic correlations among metabolic syndrome traits Faster epigenetic aging tracks metabolic syndrome risk in CARDIA Qualifiesdifferent aging/epigenetic readout — not microbiome metabolites CohortCARDIA whole-blood methylation clocks (IEAA/EEAA) related to MetS N=957 · Year-20 methylation sample with acceptable quality (year 15 n=1042) CARDIA adults with whole-blood DNA methylation at examinations 15 and/or 20 Associations of epigenetic age acceleration with MetS severity and incident MetS Higher MetS severity tracks faster epigenetic aging; year-20 IEAA predicts later incident MetS.
In CARDIA, MetS severity associated with intrinsic epigenetic age acceleration, and year-20 IEAA predicted year-30 incident MetS (OR 1.05 per unit) — a longitudinal methylation-age link, not a completed anti-aging MetS trial.
- High-phenol olive oil shifts inflammatory gene programs in MetS— acute postprandial transcript shifts after phenol-rich oil, not multi-year epigenetic clocks
Study Role Design N Population Outcome Faster epigenetic aging tracks metabolic syndrome risk in CARDIA Supports CohortCARDIA whole-blood methylation clocks (IEAA/EEAA) related to MetS N=957 · Year-20 methylation sample with acceptable quality (year 15 n=1042) CARDIA adults with whole-blood DNA methylation at examinations 15 and/or 20 Associations of epigenetic age acceleration with MetS severity and incident MetS High-phenol olive oil shifts inflammatory gene programs in MetS Qualifiesacute postprandial transcript shifts after phenol-rich oil, not multi-year epigenetic clocks RCTDouble-blind randomized crossover of high- vs low-phenol virgin olive oil breakfasts N=20 · Metabolic-syndrome patients; 398 vs 70 ppm phenol content Adults with metabolic syndrome Postprandial PBMC gene-expression differences (high vs low phenol) High-phenol virgin olive oil acutely changes inflammatory gene programs in MetS PBMCs.
In a 20-patient randomized crossover, high- vs low-phenol olive oil breakfasts altered 98 PBMC genes postprandially, including inflammation-linked transcripts — an acute meal effect, not long-term MetS remission.
- Gut microbes, blood metabolites, and metabolic traits— related MetS molecular theme, but stool microbiota/metabolites vs olive-oil PBMC transcripts
Study Role Design N Population Outcome High-phenol olive oil shifts inflammatory gene programs in MetS Supports RCTDouble-blind randomized crossover of high- vs low-phenol virgin olive oil breakfasts N=20 · Metabolic-syndrome patients; 398 vs 70 ppm phenol content Adults with metabolic syndrome Postprandial PBMC gene-expression differences (high vs low phenol) Gut microbes, blood metabolites, and metabolic traits Qualifiesrelated MetS molecular theme, but stool microbiota/metabolites vs olive-oil PBMC transcripts Cross-sectionalMETSIM subset microbiome–metabolite–metabolic trait association analysis N=531 · 531 middle-aged Finnish men from the METSIM cohort (parent cohort 10,197) Middle-aged Finnish men in METSIM Associations of gut microbiota with plasma metabolites and metabolic traits Common GWAS SNPs capture a large share of MetS-trait heritability.
SNP-based models in ARIC/FHS suggest common markers explain much previously missing heritability for MetS traits (hg² ≈ 39% of h² in the authors’ median framing), with genetic correlations tracking phenotypic ones.
- Faster epigenetic aging tracks metabolic syndrome risk in CARDIA— epigenetic aging vs common-SNP heritability — both “omic,” different questions
Study Role Design N Population Outcome Common SNPs explain much of MetS-trait heritability Supports Computational / modellingGREML-style common-SNP heritability (hg²) vs pedigree h² in ARIC (FHS checks) N=8451 · ARIC GWAS analysis population for MetS trait hg² estimates ARIC (and FHS check) participants with genome-wide SNP data and MetS traits Common-SNP heritability and genetic correlations among metabolic syndrome traits Faster epigenetic aging tracks metabolic syndrome risk in CARDIA Qualifiesepigenetic aging vs common-SNP heritability — both “omic,” different questions CohortCARDIA whole-blood methylation clocks (IEAA/EEAA) related to MetS N=957 · Year-20 methylation sample with acceptable quality (year 15 n=1042) CARDIA adults with whole-blood DNA methylation at examinations 15 and/or 20 Associations of epigenetic age acceleration with MetS severity and incident MetS
Debates
Tensions and limits
Some items are genuine disagreements on the same question. Others mark different assays, populations, or outcomes.
Microbiome correlates, methylation-age risk, acute dietary transcript shifts, and SNP heritability all sit under MetS without sharing one assay or one intervention claim.
Microbiome correlates, methylation-age risk, acute dietary transcript shifts, and SNP heritability all sit under MetS without sharing one assay or one intervention claim.
- Gut microbes, blood metabolites, and metabolic traits
- Faster epigenetic aging tracks metabolic syndrome risk in CARDIA
- High-phenol olive oil shifts inflammatory gene programs in MetS
- Common SNPs explain much of MetS-trait heritability
Study Role Design N Population Outcome Gut microbes, blood metabolites, and metabolic traits Supports Cross-sectionalMETSIM subset microbiome–metabolite–metabolic trait association analysis N=531 · 531 middle-aged Finnish men from the METSIM cohort (parent cohort 10,197) Middle-aged Finnish men in METSIM Associations of gut microbiota with plasma metabolites and metabolic traits Faster epigenetic aging tracks metabolic syndrome risk in CARDIA Supports CohortCARDIA whole-blood methylation clocks (IEAA/EEAA) related to MetS N=957 · Year-20 methylation sample with acceptable quality (year 15 n=1042) CARDIA adults with whole-blood DNA methylation at examinations 15 and/or 20 Associations of epigenetic age acceleration with MetS severity and incident MetS High-phenol olive oil shifts inflammatory gene programs in MetS Supports RCTDouble-blind randomized crossover of high- vs low-phenol virgin olive oil breakfasts N=20 · Metabolic-syndrome patients; 398 vs 70 ppm phenol content Adults with metabolic syndrome Postprandial PBMC gene-expression differences (high vs low phenol) Common SNPs explain much of MetS-trait heritability Supports Computational / modellingGREML-style common-SNP heritability (hg²) vs pedigree h² in ARIC (FHS checks) N=8451 · ARIC GWAS analysis population for MetS trait hg² estimates ARIC (and FHS check) participants with genome-wide SNP data and MetS traits Common-SNP heritability and genetic correlations among metabolic syndrome traits
PaperFren reads this as a limit on how far one study travels — different assays, populations, or outcomes — not a forced fight between papers.
A modest OR linking IEAA to incident MetS is a different clinical claim from an acute 98-gene olive-oil meal effect — both can be true without interchangeable advice.
A modest OR linking IEAA to incident MetS is a different clinical claim from an acute 98-gene olive-oil meal effect — both can be true without interchangeable advice.
- Faster epigenetic aging tracks metabolic syndrome risk in CARDIA
- High-phenol olive oil shifts inflammatory gene programs in MetS
Study Role Design N Population Outcome Faster epigenetic aging tracks metabolic syndrome risk in CARDIA Supports CohortCARDIA whole-blood methylation clocks (IEAA/EEAA) related to MetS N=957 · Year-20 methylation sample with acceptable quality (year 15 n=1042) CARDIA adults with whole-blood DNA methylation at examinations 15 and/or 20 Associations of epigenetic age acceleration with MetS severity and incident MetS High-phenol olive oil shifts inflammatory gene programs in MetS Supports RCTDouble-blind randomized crossover of high- vs low-phenol virgin olive oil breakfasts N=20 · Metabolic-syndrome patients; 398 vs 70 ppm phenol content Adults with metabolic syndrome Postprandial PBMC gene-expression differences (high vs low phenol)
PaperFren reads this as a limit on how far one study travels — different assays, populations, or outcomes — not a forced fight between papers.
Timeline
How understanding moved
Study years are when the paper was published. Evidence edits are dated changes to this page's claims. Explanations are when PaperFren added a Discovery — not a claim that the science happened that day.
2026
Concept page published
Metabolic syndrome
Change log
What changed
Dated edits to this page's evidence: studies added or removed from a claim, claims added or withdrawn, and new explanations tagged here. Coverage edits are distinct from reviewed research changes and corrections. Dates record PaperFren updates; study publication dates appear in the timeline.
- Coverage updated · Concept page published
Papers
4 studies in this library bear on Metabolic syndrome, ordered by citations.
- Gut microbes, blood metabolites, and metabolic traits
In 531 METSIM men, gut microbiota associate with plasma metabolites and metabolic-syndrome-relevant traits.
- Common SNPs explain much of MetS-trait heritability
Using ARIC/FHS SNP relationships, authors show common GWAS markers capture a large share of narrow-sense heritability for MetS-related traits (~39% of h² via hg²) and that genetic correlations between traits track phenotypic correlations.
- High-phenol olive oil shifts inflammatory gene programs in MetS
In 20 MetS patients, a randomized crossover of high-phenol (398 ppm) vs low-phenol (70 ppm) virgin olive oil breakfasts changed 98 PBMC genes postprandially, including inflammation-linked transcripts.
- Faster epigenetic aging tracks metabolic syndrome risk in CARDIA
In CARDIA adults with blood methylation clocks, higher MetS severity scores associated with intrinsic epigenetic age acceleration, and year-20 IEAA predicted incident MetS by year 30 (OR 1.05 per unit).
Compare studies
Select 2–10 studies. Design and N are labels, not a ranking.
Nothing selected yet.
Questions
What is still open
Microbiome correlates, methylation-age risk, acute dietary transcript shifts, and SNP heritability all sit under MetS without sharing one assay or one intervention claim.
A modest OR linking IEAA to incident MetS is a different clinical claim from an acute 98-gene olive-oil meal effect — both can be true without interchangeable advice.
Ask PaperFren about Metabolic syndrome
Study this conceptflashcards and short-answer questions
Why can CARDIA’s IEAA–incident MetS OR and the olive-oil 98-gene crossover both be valid without being one claim?
One links multi-year epigenetic age acceleration to later syndrome incidence; the other is an acute meal-driven transcript contrast. Different time scales, exposures, and endpoints.
A student says SNP heritability of MetS traits means diet cannot matter. What is wrong?
Heritability describes additive genetic share of variance in a population/time; it does not imply traits are immutable or that environment/lifestyle have no effect.